课题基金 / 基金详情

项目摘要

项目成果

Jianxin Bao的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Age related functional decline of nervous system is consistently observed, the sequence of causative molecular events for age related functional decline is unknown. This proposal focuses on possible roles of transmembrane Neuregulin-1 (Nrg-1) may have on this aging process. Our recent work revealed: (a) the cytoplasmic domain of Neuregulin-1 (Nrg-ICD) can translocate into the nucleus and regulate gene expression including that of PSD-95 and apoptotic genes; (b) Nrg-ICD regulates PSD-95 expression by binding to a transcription factor, Eos, and (c) during aging there is a correlation between nuclear translocation of Nrg-ICD and up-regulation of PSD-95 and BAK, a pro-apoptotic gene. The general hypothesis is that NRG-1 plays an essential role in age related neuronal changes. To test this hypothesis, we have made a conditional tissue-specific transgenic mouse model, which conditionally expresses Nrg-1 in several specific regions including hippocampus, spiral ganglion neurons, and outer-hair cells. By taking advantage of this mouse model, we will examine three related issues: (1) whether conditional overexpression of Nrg-1 in adult mice can alter age related hearing loss; (2) whether a conditional overexpression of Nrg-1 in adult mice can alter age related neuronal changes in hippocampus; (3) whether caloric restriction, the most effective way to delay the aging process, affects the role of Nrg-1 signaling pathways on age related neuronal changes. The ultimate goal of our research is to develop methods for prevention and treatment of age related functional decline of nervous system based on identifying molecular candidates involved in the aging process
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
STAT5 mediates antiapoptotic effects of methylprednisolone on oligodendrocytes.
STAT5 介导甲基强的松龙对少突胶质细胞的抗凋亡作用。
DOI: 10.1523/jneurosci.2621-08.2009
发表时间: 2009
期刊: The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子: --
作者: [Xu,Jan, Chen,Shawei, Chen,Hong, Xiao,Qingli, Hsu,ChungY, Michael,Drew, Bao,Jianxin]
通讯作者: Bao,Jianxin
DOI: 10.1016/j.heares.2011.05.010
发表时间: 2011-08
期刊: HEARING RESEARCH
影响因子: 2.8
作者: [Lei, Debin, Gao, Xia, Perez, Philip, Ohlemiller, Kevin K., Chen, Chien-Chang, Campbell, Kevin P., Hood, Aizhen Yang, Bao, Jianxin]
通讯作者: Bao, Jianxin
DOI: 10.1016/j.heares.2011.01.009
发表时间: 2011-07
期刊: HEARING RESEARCH
影响因子: 2.8
作者: [Shen, Haiyan, Lin, Zhaoyu, Lei, Debin, Han, Josiah, Ohlemiller, Kevin K., Bao, Jianxin]
通讯作者: Bao, Jianxin
DOI: 10.1016/j.heares.2009.10.009
发表时间: 2010-06-01
期刊: HEARING RESEARCH
影响因子: 2.8
作者: [Bao, Jianxin, Ohlemiller, Kevin K.]
通讯作者: Ohlemiller, Kevin K.
6
    Targeting multiple signaling pathways for tinnitus prevention and treatment
    • 批准号:
      10197878
    • 项目类别:
    • 资助金额:
      $120.73万
    • 财政年份:
      2020
    • 负责人:
      Jianxin Bao
    • 依托单位:
    Targeting multiple signaling pathways for tinnitus prevention and treatment
    • 批准号:
      10010292
    • 项目类别:
    • 资助金额:
      $97.26万
    • 财政年份:
      2020
    • 负责人:
      Jianxin Bao
    • 依托单位:
    An unique patient population for clinical trials against noise-induced hearing loss
    • 批准号:
      10006932
    • 项目类别:
    • 资助金额:
      $9.99万
    • 财政年份:
      2018
    • 负责人:
      Jianxin Bao
    • 依托单位:
    Develop a new cisplatin-based drug combination with reduced ototoxicity
    • 批准号:
      9408928
    • 项目类别:
    • 资助金额:
      $22.47万
    • 财政年份:
      2017
    • 负责人:
      Jianxin Bao
    • 依托单位:
    海外基金